Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.

A prospective randomized study was conducted to determine the efficacy of imipenem-cilastatin (hereafter referred to as imipenem) (500 mg four times daily) versus combination therapy for febrile neutropenic patients receiving either no prophylaxis or ciprofloxacin for prevention of infections. Combi...

詳細記述

書誌詳細

出版年:	Antimicrob Agents Chemother
主要な著者:	Cornelissen, J J, de Graeff, A, Verdonck, L F, Branger, T, Rozenberg-Arska, M, Verhoef, J, Dekker, A W
フォーマット:	Artigo
言語:	Inglês
出版事項:	American Society for Microbiology (ASM) 1992
主題:	Research Article
オンライン･アクセス:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189424/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1503442/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.36.4.801
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!